Zydus Lifesciences Limited (NSE:ZYDUSLIFE)

India · Delayed Price · Currency is INR

896.70

-7.00 (-0.77%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	205.44B	172.35B	149.93B	131.31B	125.63B
Pharmaceuticals Growth	19.20%	14.96%	14.18%	4.53%	0.38%
Consumer Products	26.98B	23.12B	22.45B	19.79B	18.41B
Consumer Products Growth	16.68%	2.99%	13.44%	7.49%	5.93%
Total	232.42B	195.47B	172.37B	151.10B	144.04B
Total Growth	18.90%	13.40%	14.08%	4.90%	1.06%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	92.53B	80.15B	76.40B	70.98B	58.59B
India Growth	15.44%	4.91%	7.64%	21.14%	-9.05%
United States	111.41B	87.75B	74.87B	59.49B	64.49B
United States Growth	26.96%	17.21%	25.86%	-7.75%	2.29%
Others	28.47B	27.57B	21.11B	20.63B	20.96B
Others Growth	3.29%	30.61%	2.30%	-1.56%	39.10%
Total	232.42B	195.47B	172.37B	151.10B	144.04B
Total Growth	18.90%	13.40%	14.08%	4.90%	1.06%

Source: S&P Global Market Intelligence.